DuPont (NYSE:DD) released its 2016 second quarter earnings report recently.  The company’s revenues declined for the quarter, while operating earnings jumped 11%, with most of the increase coming from Agriculture and Nutrition & Health segments. With regards to DuPont’s planned merger with The Dow Chemical Company (NYSE:DOW), the stockholders of both companies recently approved the deal.  The merger now needs to be approved by the antitrust authorities and the DuPont management remains confident the deal will be completed in the second half of 2016. 
The following table provides an overview of the company’s earnings.
- DuPont Earnings Preview: Meaningful Improvement In Growth Is Suspect
- DuPont: The Year 2016 In Review
- Key Takeaways From DuPont’s Q3 Earnings
- DuPont Q3 Earnings Preview: No Surprises Expected, Focus To Remain On Merger With Dow
- Dissecting Dow And DuPont Deal, Part 4: Concern Over Concentration
- Dissecting Dow And DuPont Deal, Part 3: Why Merge And Split?
- How Much Did Dupont’s Revenue & EBITDA Grow In The Last Four Years?
- How Much Can Dupont’s Revenue Grow In The Next Five Years?
- What Is Dupont’s Revenue & EBITDA Breakdown?
- What is Dupont’s Fundamental Value Based On Expected 2016 Results?
- How Has Dupont’s Revenue Composition Changed In The Last Four Years?
- How Can Dupont’s Revenue Composition Change In The Next Five Years?
- DuPont Reports Second-Quarter 2016 Results, July 26, 2016, DuPont Investor Relations [↩]
- Dow And DuPont Stockholders Approve Merger, July 20, 2016, DuPont Investor Relations [↩]
- E.I. du Pont de Nemours & Co. (DD) Edward D. Breen on Q2 2016 Results – Earnings Call Transcript, July 26, 2016, Seeking Alpha [↩]